COMMUNIQUÉS West-GlobeNewswire

CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference
29/07/2025
MINNEAPOLIS, July 29, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
The International Myeloma Foundation Mourns the Loss of Accomplished Attorney and Longtime Board Member Benson Klein
29/07/2025
STUDIO CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announces with great sadness the passing of our beloved and longtime Board Member Benson Klein, JD. After living [...]
Cannabix Technologies Receives Notice of Allowance from CIPO for Contactless Breath Analysis Patent Application
29/07/2025
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the Canadian Intellectual [...]
New Imprivata Report: Hospitals Save an Average of $1.1M Annually with Shared Mobile Devices, But Most Still Lack a Formal Use Policy
29/07/2025
Shared mobile devices deliver significant benefits to clinical workflows and patient care, but gaps in user experience, oversight, and policy enforcement still limit their full impact WALTHAM, Mass., July 29, 2025 ( [...]
Concept Life Sciences & Fios Genomics Partner to Enhance Complex Data Analysis in Drug Discovery
29/07/2025
Strategic alliance based in the Edinburgh BioQuarter provides clients with richer data analysis, driving smarter, data-driven decisions CHAPEL-EN-LE-FRITH and EDINBURGH, United Kingdom, July 29, 2025 (GLOBE NEWSWIRE [...]
Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain
29/07/2025
Celanese’s VitalDose ® Drug Delivery Platform will enable a long-acting, patient-centric formulation for Meliodays’ IUD design MUNICH, July 29, 2025 (GLOBE NEWSWIRE) -- Meliodays Medical and Celanese Corporation (NYSE: [...]
Philips builds strong order intake momentum and drives margin expansion in Q2
29/07/2025
July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6% Group sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 [...]
Indonesia’s Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces
29/07/2025
July 29, 2025 Long-term multiyear agreements will see Philips installing its advanced Azurion image-guided therapy systems nationwide across all provinces, including rural and remote areas Initiative brings minimally [...]
Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections
29/07/2025
Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infections Study completion expected in Q1 2028 Allschwil, Switzerland, July 29, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: [...]
LIfT BioSciences announces grant of €12 million from Ireland’s Disruptive Technologies Innovation Fund to support the first-in-human clinical trial of LIfT’s IMAN therapy
29/07/2025
Galway, London, 29 July 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today announces a grant of €12 million has been awarded from [...]
Regional Health Properties, Inc. Outlines Reasons for Regional Shareholders to Vote YES for Proposed Merger with SunLink Health Systems, Inc.
29/07/2025
ATLANTA, GA, July 28, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB), a self-managed healthcare real estate investment company that invests primarily [...]
Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger - CrazyBulk
29/07/2025
New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements . Explore the best stacks for real power gains in 2025 In the [...]
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
29/07/2025
Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits Broad label includes adults and adolescents with C3G or [...]
Unity Consortium Announces Publication of Journal of Adolescent Health Supplement: “Expert Perspectives on Evolving Adolescent Well Visits and Immunization Platforms”
28/07/2025
Supplement provides a timely and comprehensive review of adolescent immunization platforms, offering practical insights for healthcare providers navigating a shifting public health landscape VENTNOR CITY, N.J., July 28 [...]
Neurogen Biomarking Virtual Care Ecosystem Cuts Time to Alzheimer’s Intervention by 4.5 Years, AAIC 2025 Presentation Findings Show
28/07/2025
Progress in validating in-home blood test, combined with cognitive assessment and specialty virtual care, break through barriers to early detection Key Takeaways Findings from breakthrough approach to early detection [...]
How to Build Muscle Fast for Beginners And Skinny Guys: with CrazyBulk Legal Steroids for Muscle Endurance A Guide in 2025 For Bodybuilders Muscle Growth
28/07/2025
How to Build Muscle Fast for Beginners And Skinny Guys: with CrazyBulk Muscle-Building Supplements, The Ultimate Guide for 2025 Los Angeles, CA, July 28, 2025 (GLOBE NEWSWIRE) -- For beginners looking to build muscle [...]
SonderCare Launches Certified Home Hospital Beds to Support 16 Million Middle-Income Seniors Facing Long-Term Care Crisis
28/07/2025
Certified Premium Hospital Beds Offer Practical Solution for Families Navigating the "Missing Middle" of Senior Care London, ON , July 28, 2025 (GLOBE NEWSWIRE) -- SonderCare , a leading manufacturer of home-based [...]
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
28/07/2025
CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress
28/07/2025
MET-097i (fully biased once-monthly GLP-1 RA) VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered class- [...]

Pages